Zepbound trims more belly fat than Wegovy, study shows

siliconvalley.com/2025/05/12/lillys-zepbound-trims-more-belly-fat-than-novos-wegovy

By Naomi Kresge | Bloomberg
Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the first head-to-head study of the rival medicines.
Zepbound won on all measures of effectiveness in a trial presented Monday…

This story appeared on siliconvalley.com, 2025-05-12 18:41:52.
The Entire Business World on a Single Page. Free to Use →